CSWI Form 4: CEO’s 1,000-Share Sale Under 10b5-1 Plan

Rhea-AI Filing Summary

CSW Industrials, Inc. (CSWI) – Form 4 insider transaction dated 15 July 2025

Chairman, President & CEO Joseph B. Armes reported the sale of 1,000 shares of CSWI common stock pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on 12 Sept 2024. The shares were sold in 12 small blocks at weighted-average prices ranging from $291.77 – $305.35, generating an estimated $0.3 million in gross proceeds.

Following the transactions, Armes’ direct ownership declined from 64,572 to 63,572 shares, a reduction of roughly 1.5 %. He also continues to hold 3,219 shares indirectly through the company ESOP, plus sizable equity incentives:

• Performance Rights: 8,004; 8,236; 12,422; and 18,372 units across four three-year TSR cycles.
• Restricted Stock Units: 19,685 units, vesting contingent on CEO succession milestones (40 % upon recruitment of a successor, 60 % after the successor’s first employment anniversary).

No derivative transactions occurred; the filing merely restates outstanding awards.

The modest sale size, pre-planned nature, and continued significant equity stake suggest limited signalling value, but investors often monitor any CEO disposition. The new RSU structure ties a large portion of future vesting to a smooth leadership transition, aligning management incentives with succession execution and long-term TSR.

Positive

• Sale executed under a pre-arranged Rule 10b5-1 plan, reducing insider-trading risk.
• CEO retains a substantial equity position (>63 k shares direct, 3.2 k indirect) plus performance-based awards, maintaining alignment with shareholders.
• Succession-linked RSUs incentivise smooth leadership transition and long-term value creation.

Negative

• Insider sale by the CEO, even if small, can be perceived as a lack-of-confidence signal by some investors.
• Reduction of direct holdings by 1.5 % slightly lowers management’s economic exposure.

Insights

Securities Analyst

TL;DR: CEO sold 1,000 shares (~$0.3 m) under 10b5-1; stake remains large, signalling impact modest.

The transaction represents roughly 1.5 % of Mr. Armes’ direct holdings and less than 0.1 % of CSWI’s ~15 m share float, therefore unlikely to create material supply pressure. Because the sale was executed under a Rule 10b5-1 plan established months earlier, informational asymmetry concerns are muted. Armes retains >63 k shares plus >66 k performance-linked units, maintaining strong alignment with shareholder outcomes. The filing also clarifies multi-year TSR-based awards and succession-linked RSUs, which reinforce long-term incentive alignment. Overall, the Form 4 is neutral from a valuation perspective.

Corporate Governance Expert

TL;DR: Minor pre-scheduled sale; new RSUs highlight succession planning and incentive alignment.

Insider sales often raise governance flags, but context matters. A 10b5-1 plan reduces potential insider-trading concerns, and a 1,000-share sale by a CEO with >63 k shares outstanding signals routine liquidity rather than negative outlook. Notably, the RSUs vest only after the company successfully recruits and retains a successor CEO, indicating the board’s proactive approach to leadership transition and retention risk. The multi-tranche performance rights tied to relative TSR further link pay to performance. From a governance standpoint, actions appear shareholder-friendly and impact is neutral to slightly positive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Armes Joseph B

(Last) (First) (Middle)

5420 LYNDON B JOHNSON FWY

STE. 500

(Street)

DALLAS TX 75240-1007

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CSW INDUSTRIALS, INC. [ CSWI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2025		S(1)		234	D	$291.77(2)	64,288	D
Common Stock	07/15/2025		S(1)		123	D	$292.94(3)	64,165	D
Common Stock	07/15/2025		S(1)		174	D	$293.84(4)	63,991	D
Common Stock	07/15/2025		S(1)		132	D	$294.76(5)	63,859	D
Common Stock	07/15/2025		S(1)		110	D	$295.7(6)	63,749	D
Common Stock	07/15/2025		S(1)		59	D	$296.98(7)	63,690	D
Common Stock	07/15/2025		S(1)		53	D	$298.16(8)	63,637	D
Common Stock	07/15/2025		S(1)		41	D	$299.39(9)	63,596	D
Common Stock	07/15/2025		S(1)		14	D	$300.13(10)	63,582	D
Common Stock	07/15/2025		S(1)		10	D	$301.99	63,572	D
Common Stock	07/15/2025		S(1)		28	D	$303.92(11)	63,544	D
Common Stock	07/15/2025		S(1)		22	D	$305.35(12)	63,522	D
Common Stock								3,219	I	by ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Rights	(13)							(13)	(13)	Common Stock	8,004		8,004	D
Performance Rights	(14)							(14)	(14)	Common Stock	8,236		8,236	D
Performance Rights	(15)							(15)	(15)	Common Stock	12,422		12,422	D
Performance Rights	(16)							(16)	(16)	Common Stock	18,372		18,372	D
Restricted Stock Units	(17)							(17)	(17)	Common Stock	19,685		19,685	D

Explanation of Responses:

1. The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $291.31 to $292.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $292.34 to $293.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $293.36 to $294.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

5. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $294.37 to $295.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

6. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $295.39 to $296.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

7. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $296.53 to $297.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

8. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $297.67 to $298.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

9. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.04 to $299.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

10. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.05 to $300.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

11. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $303.34 to $304.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

12. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.16 to $305.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

13. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025 and ending on March 31, 2028 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

14. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024 and ending on March 31, 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

15. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023 and ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

16. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles beginning April 1, 2021 ending on each of March 31, 2026 and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

17. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest no earlier than April 26, 2025 upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.

Remarks:

	/s/Luke E. Alverson, Attorney in Fact	07/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CSWI shares did CEO Joseph B. Armes sell on 15 July 2025?

He sold 1,000 shares in 12 separate transactions.

At what prices were the CSWI shares sold?

Weighted-average prices ranged from $291.77 to $305.35 per share.

Was the sale part of a 10b5-1 trading plan?

Yes. The plan was adopted on 12 September 2024, indicating the sales were pre-scheduled.

What is Joseph B. Armes’ current CSWI share ownership after the sale?

He directly owns 63,572 shares and indirectly holds 3,219 shares through the ESOP.

Does the filing disclose any new equity awards?

No new awards were granted; it only restates existing Performance Rights (≈47 k units) and 19,685 RSUs.

Why do the RSUs depend on CEO succession?

40 % vest upon hiring a successor CEO and 60 % vest after the successor’s first anniversary, aligning incentives with a smooth transition.